Press Release

Saudi Arabia Antibiotics Market to grow with a CAGR of 4.78%

Increasing healthcare infrastructure and a supportive regulatory environment are the major drivers for the Saudi Arabia Antibiotics Market.

 

According to TechSci Research report, “Saudi Arabia Antibiotics Market Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028”, Saudi Arabia Antibiotics Market has valued at USD 0.90 billion in 2022 and is anticipated to witness an impressive growth in the forecast period with a CAGR of 4.78% through 2028.   This can be due to collaborations and partnerships among leading companies with a diverse approach to merge the expertise of individual companies and to strengthen their position in the market.

 Rising awareness about healthcare and the importance of responsible antibiotic use can indeed drive the demand for antibiotics. As people become more health-conscious and informed, they may be more likely to seek medical attention when they suspect an infection that requires antibiotic treatment. This increased patient demand can drive prescription rates. A population that is more aware of the potential risks of untreated infections and the benefit of antibiotic treatment is more likely to visit healthcare providers when necessary. This can result in a higher demand for antibiotics. Government and healthcare organizations often run public health campaigns to educate the public about various health issues, including the responsible use of antibiotics. These campaigns can influence public behavior and increase awareness about the importance of appropriate antibiotic use.

Healthcare providers, including doctors and pharmacists, are often at the forefront of educating patients about antibiotics. Increased awareness among healthcare professionals can lead to more responsible antibiotic prescribing and dispensing. Many countries participate in global antibiotic awareness campaigns and initiatives like World Antibiotic Awareness Week. These events draw attention to the issue of antibiotic resistance and encourage responsible antibiotic use.

 

Browse over XX market data Figures and spread through XX Pages and an in-depth TOC on Saudi Arabia Antibiotics Market.”

 

In March 2022, Cumberland Pharmaceuticals Inc., headquartered in Nashville, and Tabuk Pharmaceutical Manufacturing Company, a fully owned subsidiary of Astra Industrial Group and a leading pharmaceutical company in the Middle East, headquartered in Riyadh, Saudi Arabia, have jointly announced the introduction of Cumberland's Vibativ (telavancin) injection in the Middle East. This announcement follows a collaboration between the two companies, granting Tabuk exclusive rights to register and promote the product for patients in Saudi Arabia, Jordan, and potentially other Middle Eastern countries. Vibativ represents a potentially life-saving treatment for patients with hospital-acquired and ventilator-associated pneumonia caused by various Gram-positive bacterial pathogens, including those that are difficult to treat and multidrug-resistant.

Generic competition is a challenge in the Saudi Arabia antibiotics market, as it is in pharmaceutical markets worldwide. When the patents for brand-name antibiotics expire, generic pharmaceutical companies can produce and market equivalent versions, often at a lower cost. This can lead to increased competition for the same antibiotics. Generic antibiotics are typically more cost-effective than their brand-name counterparts, which can put pressure on the prices of antibiotics in the market. This can be beneficial for patients and healthcare systems but may reduce the profitability of antibiotic manufacturers. As more generic versions of antibiotics become available, the market may become saturated with multiple competing products. This can lead to price wars and further price reductions.  Healthcare providers may increasingly prescribe generic antibiotics to reduce healthcare costs, which can influence patient and pharmacy choices. Patients and healthcare providers may become less loyal to specific brand-name antibiotics when effective and more affordable generic alternatives are available.

Saudi Arabia Antibiotics Market is segmented based on Drug Class, Spectrum, Source, Route of Administration, Distribution Channel, and by region.

Based on the Spectrum, Saudi Arabia Antibiotics Market is segmented into Broad Spectrum Antibiotics, Narrow Spectrum Antibiotics. Broad-spectrum antibiotics are a category of antibiotics that are effective against a wide range of different types of bacteria. These antibiotics are capable of targeting and killing a diverse group of bacteria, including both Gram-positive and Gram-negative bacteria. Broad-spectrum antibiotics are versatile and can be used to treat a wide variety of bacterial infections when the specific type of bacteria causing the infection is unknown or when multiple types of bacteria are involved. They are effective against both Gram-positive and Gram-negative bacteria. This includes common bacteria responsible for a range of infections, such as Staphylococcus, Streptococcus, Escherichia coli, and Pseudomonas aeruginosa. Broad-spectrum antibiotics are often used in clinical practice when there is uncertainty about the precise bacterial cause of an infection or in severe infections where a rapid response is essential and waiting for detailed diagnostic information may be impractical. Some examples of broad-spectrum antibiotics include certain penicillins, cephalosporins, fluoroquinolones, and carbapenems. These antibiotics have a broad spectrum of activity and can target a wide range of bacteria.

Based on Region, Northern & Central region held the largest share in the Saudi Arabia Antibiotics Market. The Saudi government often directs healthcare investments towards these regions due to their importance in terms of population and economic activity. This can lead to more healthcare facilities and resources available for antibiotic distribution. Major pharmaceutical companies and distributors are likely to be concentrated in these regions, ensuring a steady supply of antibiotics. There may be a greater level of health awareness and education in these regions, which can influence healthcare-seeking behavior and responsible antibiotic use.

 

Some of the major companies operating in the Saudi Arabia Antibiotics Market include:

  • Novartis AG Saudi Arabia
  • Pfizer Saudi Limited
  • Glenmark Pharmaceuticals Saudi Arabia
  • GlaxoSmithKline Saudi Arabia Limited
  • AstraZeneca Saudi Arabia

 

Download Free Sample Report

Customers can also request 10% free customization on this report.

 

“Certain areas, particularly in North America, are projected to exert significant demand for Antibiotics. The growth in the competitive landscape and the presence of well-established companies in the market, committed to enhance the overall wellbeing of people each year, are expected to contribute to a remarkable growth of the Saudi Arabia Antibiotics Market in the forecast period," said Mr. Karan Chechi, Research Director with TechSci Research, a research-based Global management consulting firm.

Saudi Arabia Antibiotics Market by Drug Class (Cephalosporin, Penicillin, Amoxicillin, Azithromycin, Clindamycin, Tetracycline, Others), By Spectrum (Broad Spectrum Antibiotics, Narrow Spectrum Antibiotics), By Source (Natural, Semisynthetic, Synthetic), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region, By Competition Forecast & Opportunities, 2018-2028F has evaluated the future growth potential of Saudi Arabia Antibiotics Market and provides statistics & information on market size, structure, and future market growth. The report intends to provide innovative market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Saudi Arabia Antibiotics Market.

 

Contact Us-

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

M: +13322586602

Email: [email protected]

Website: www.techsciresearch.com

Relevant News